Tegmine Therapeutics
The startup has developed an antibody-based therapeutics platform that utilizes mass spectrometry and machine learning to identify tumor-specific protein modifications that contribute to cancer progression. This technology enables the creation of targeted antibody drugs that minimize damage to healthy tissues while effectively treating tumors.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed an antibody-based therapeutics platform that utilizes mass spectrometry and machine learning to identify tumor-specific protein modifications that contribute to cancer progression. This technology enables the creation of targeted antibody drugs that minimize damage to healthy tissues while effectively treating tumors.